<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37967057</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>11</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Online search interest in long-term symptoms of coronavirus disease 2019 during the COVID-19 pandemic in Japan: Infodemiology study using the most visited search engine in Japan.</ArticleTitle><Pagination><StartPage>e0294261</StartPage><MedlinePgn>e0294261</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0294261</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0294261</ELocationID><Abstract><AbstractText>Prolonged symptoms that occur after COVID-19 (long-COVID) vary from mild, which do not interfere with daily life, to severe, which require long-term social support. This study assessed the secular trend in online searches on long-COVID in Japan. We conducted an observational study using data provided by Yahoo! JAPAN on the monthly search volume of query terms related to long-COVID from January 2020 to December 2022, including the search volume of the query "&#x30b3;&#x30ed;&#x30ca;" (long-COVID in Japanese). The number of new cases of COVID-19 by month was used as a control for search trends, and the symptoms retrieved in conjunction with long-COVID were compared. Trends in online searches for each symptom of long-COVID were analyzed. The symptoms of long-COVID were classified according to "Component 1-Symptoms and Complaints" of the International Classification of Primary Care, 2nd edition (ICPC-2). Interest in long-COVID increased in response to peaks in the number of new cases of COVID-19 in Japan. The most frequent symptom searches with long-COVID were hair loss/baldness (3,530, 21,400, and 33,600 searches in 2020, 2021, and 2022, respectively), cough (340, 7,900 and 138,910 searches in 2020, 2021, and 2022, respectively), disturbance of smell/taste (230, 13,340, and 44,160 searches in 2020, 2021, and 2022, respectively), and headache (580, 6,180, and 42,870 searches in 2020, 2021, and 2022, respectively). In addition, the ranking of interest in "weakness/tiredness, general" in long-COVID increased each year (not in the top 10 in 2020, seventh in 2021, and second in 2022), and the absolute number of searches also increased. To our knowledge, this is the first study to investigate secular trends in online interest in long-COVID in the world. Continued monitoring of online interest in long-COVID is necessary to prepare for a possible increase in the number of patients with long-COVID.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 Ishizuka et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ishizuka</LastName><ForeName>Kosuke</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-4313-6592</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Yokohama City University School of Medicine, Yokohama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyagami</LastName><ForeName>Taiju</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsuchida</LastName><ForeName>Tomoya</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saita</LastName><ForeName>Mizue</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohira</LastName><ForeName>Yoshiyuki</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-2606-3611</Identifier><AffiliationInfo><Affiliation>Division of General Internal Medicine, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naito</LastName><ForeName>Toshio</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-1646-9930</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057386" MajorTopicYN="N">Search Engine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000090462" MajorTopicYN="N">Infodemiology</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>17</Day><Hour>15</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>15</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>15</Day><Hour>13</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37967057</ArticleId><ArticleId IdType="pmc">PMC10650984</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0294261</ArticleId><ArticleId IdType="pii">PONE-D-23-28136</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020; 20: 533&#x2013;4. doi: 10.1016/S1473-3099(20)30120-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30120-1</ArticleId><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review. JAMA Netw Open. 2021; 4: e2111417. doi: 10.1001/jamanetworkopen.2021.11417</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Perego E. Post on X/Twitter. May 20, 2020. Available at: https://twitter.com/elisaperego78/status/1263172084055838721?s=20. [accessed October 22, 2023]</Citation></Reference><Reference><Citation>Callard F, Perego E. How and why patients made Long Covid. Soc Sci Med. 2021; 268: 113426. doi: 10.1016/j.socscimed.2020.113426</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M, Beckwith H, Spratt T, Vallejos EP, Coughlan B. The #longcovid revolution: A reflexive thematic analysis. Soc Sci Med. 2023; 333: 116130. doi: 10.1016/j.socscimed.2023.116130</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2023.116130</ArticleId><ArticleId IdType="pubmed">37573677</ArticleId></ArticleIdList></Reference><Reference><Citation>X/Twitter. Number of monetizable daily active X (formerly Twitter) users (mDAU) worldwide from 1st quarter 2017 to 2nd quarter 2022. Available at: https://www.statista.com/statistics/970920/monetizable-daily-active-twitter-users-worldwide/. [accessed October 22, 2023]</Citation></Reference><Reference><Citation>World Health Organization. A clinical case definition of post-COVID-19 condition by a Delphi consensus, 6 October 2021. Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1. [accessed August 11, 2023]</Citation></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV; WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022; 22: e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM; Lifelines Corona Research Initiative. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022; 400: 452&#x2013;461. doi: 10.1016/S0140-6736(22)01214-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q, Zheng B, Daines L, Sheikh A. Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms. Pathogens. 2022; 11: 269. doi: 10.3390/pathogens11020269</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, et al.. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022; 28: 1706&#x2013;14. doi: 10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, et al.. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022; 13: 1957. doi: 10.1038/s41467-022-29521-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchida T, Yoshimura N, Ishizuka K, et al.. Five cluster classifications of long COVID and their background factors: A cross-sectional study in Japan. Clin Exp Med. 2023: 1&#x2013;8. doi: 10.1007/s10238-023-01057-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-023-01057-6</ArticleId><ArticleId IdType="pmc">PMC10081305</ArticleId><ArticleId IdType="pubmed">37027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Eysenbach G. Infodemiology and infoveillance: framework for an emerging set of public health informatics methods to analyze search, communication and publication behavior on the Internet. J Med Internet Res. 2009; 11: e11. doi: 10.2196/jmir.1157</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.1157</ArticleId><ArticleId IdType="pmc">PMC2762766</ArticleId><ArticleId IdType="pubmed">19329408</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins TS, Wu AW, Sharma D, Illing EA, Rubel K, Ting JY; Snot Force Alliance. Correlations of Online Search Engine Trends With Coronavirus Disease (COVID-19) Incidence: Infodemiology Study. JMIR Public Health Surveill. 2020; 6: e19702. doi: 10.2196/19702</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/19702</ArticleId><ArticleId IdType="pmc">PMC7244220</ArticleId><ArticleId IdType="pubmed">32401211</ArticleId></ArticleIdList></Reference><Reference><Citation>Statista Research Department. Most visited websites in Japan 2021, by monthly traffic. Available at: https://www.statista.com/statistics/1135567/japan-most-visited-websites-by-average-monthly-traffic/. [accessed August 11, 2023].</Citation></Reference><Reference><Citation>Ministry of Health, Labour and Welfare, Japan. Visualizing the data: information on COVID-19 infections. Available at: https://covid19.mhlw.go.jp/en/. [accessed August 11, 2023].</Citation></Reference><Reference><Citation>WONCA International Classification Committee. ICPC-2: International classification of primary care. 2nd ed. Oxford: Oxford Medical Publication; 1998.</Citation></Reference><Reference><Citation>Ministry of Health, Labour and Welfare, Japan. Japanese Ethical Guidelines for Medical and Health Research Involving Human Subjects. Available at: https://www.mhlw.go.jp/file/06-Seisakujouhou-10600000-Daijinkanboukouseikagakuka/0000153339.pdf. [accessed August 11, 2023].</Citation></Reference><Reference><Citation>World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013; 310: 2191&#x2013;4. doi: 10.1001/jama.2013.281053</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.281053</ArticleId><ArticleId IdType="pubmed">24141714</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler CX, Wyller VBB, Moss-Morris R, et al.. Long COVID and Post-infective Fatigue Syndrome: A Review. Open Forum Infect Dis. 2021; 8: ofab440. doi: 10.1093/ofid/ofab440</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab440</ArticleId><ArticleId IdType="pmc">PMC8496765</ArticleId><ArticleId IdType="pubmed">34631916</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazato Y, Morioka S, Tsuzuki S, et al.. Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019. Open Forum Infect Dis. 2020; 7: ofaa507. doi: 10.1093/ofid/ofaa507</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa507</ArticleId><ArticleId IdType="pmc">PMC7665672</ArticleId><ArticleId IdType="pubmed">33230486</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain N, Agarwala P, Iqbal K, et al.. A systematic review of acute telogen effluvium, a harrowing post-COVID-19 manifestation. J Med Virol. 2022; 94: 1391&#x2013;401. doi: 10.1002/jmv.27534</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27534</ArticleId><ArticleId IdType="pubmed">34931698</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilinska K, Butowt R. Anosmia in COVID-19: A Bumpy Road to Establishing a Cellular Mechanism. ACS Chem Neurosci. 2020; 11: 2152&#x2013;5. doi: 10.1021/acschemneuro.0c00406</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00406</ArticleId><ArticleId IdType="pmc">PMC7467568</ArticleId><ArticleId IdType="pubmed">32673476</ArticleId></ArticleIdList></Reference><Reference><Citation>UK Health Security Agency. SARS-CoV-2 variants of concern and variants under investigation in England, Technical briefing 34, https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1050236/technical-briefing-34-14-january-2022.pdf. [accessed August 11, 2023].</Citation></Reference><Reference><Citation>Boscolo-Rizzo P, Tirelli G, Meloni P, et al.. Coronavirus disease 2019 (COVID-19)-related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Omicron variant. Int Forum Allergy Rhinol. 2022; 12: 1273&#x2013;81. doi: 10.1002/alr.22995</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alr.22995</ArticleId><ArticleId IdType="pmc">PMC9082058</ArticleId><ArticleId IdType="pubmed">35286777</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, et al.. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur J Intern Med. 2021; 92: 55&#x2013;70. doi: 10.1016/j.ejim.2021.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolay H, G&#xfc;l A, Baykan B. COVID-19 is a Real Headache! Headache. 2020; 60: 1415&#x2013;21. doi: 10.1111/head.13856</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.13856</ArticleId><ArticleId IdType="pmc">PMC7272895</ArticleId><ArticleId IdType="pubmed">32412101</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna E, Alpuente A, Torres-Ferrus M, Pozo-Rosich P. Toward a better understanding of persistent headache after mild COVID-19: Three migraine-like yet distinct scenarios. Headache. 2021; 61: 1277&#x2013;80. doi: 10.1111/head.14197</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.14197</ArticleId><ArticleId IdType="pmc">PMC8444902</ArticleId><ArticleId IdType="pubmed">34363619</ArticleId></ArticleIdList></Reference><Reference><Citation>Ormiston CK, &#x15a;wi&#x105;tkiewicz I, Taub PR. Postural orthostatic tachycardia syndrome as a sequela of COVID-19. Heart Rhythm. 2022; 19: 1880&#x2013;9. doi: 10.1016/j.hrthm.2022.07.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2022.07.014</ArticleId><ArticleId IdType="pmc">PMC9287587</ArticleId><ArticleId IdType="pubmed">35853576</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023; 21: 133&#x2013;46. doi: 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Poenaru S, Abdallah SJ, Corrales-Medina V, Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review. Ther Adv Infect Dis. 2021; 8: 20499361211009385. doi: 10.1177/20499361211009385</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20499361211009385</ArticleId><ArticleId IdType="pmc">PMC8060761</ArticleId><ArticleId IdType="pubmed">33959278</ArticleId></ArticleIdList></Reference><Reference><Citation>Villalpando JMG, Forcelledo HA, Castillo JLB, et al.. COVID-19, Long COVID Syndrome, and Mental Health Sequelae in a Mexican Population. Int J Environ Res Public Health. 2022; 19: 6970. doi: 10.3390/ijerph19126970</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19126970</ArticleId><ArticleId IdType="pmc">PMC9222368</ArticleId><ArticleId IdType="pubmed">35742219</ArticleId></ArticleIdList></Reference><Reference><Citation>Case KR, Wang CP, Hosek MG, et al.. Health-related quality of life and social determinants of health following COVID-19 infection in a predominantly Latino population. J Patient Rep Outcomes. 2022; 6: 72. doi: 10.1186/s41687-022-00473-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41687-022-00473-8</ArticleId><ArticleId IdType="pmc">PMC9219362</ArticleId><ArticleId IdType="pubmed">35737279</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff ER, Madlock-Brown C, Baratta JM, et al.. Coding long COVID: characterizing a new disease through an ICD-10 lens. BMC Med. 2023; 21: 58. doi: 10.1186/s12916-023-02737-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-02737-6</ArticleId><ArticleId IdType="pmc">PMC9931566</ArticleId><ArticleId IdType="pubmed">36793086</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>